203 related articles for article (PubMed ID: 8221571)
21. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
Wu CS; Pollack A; Czerniak B; Chyle V; Zagars GK; Dinney CP; Hu SX; Benedict WF
Urology; 1996 Mar; 47(3):305-10. PubMed ID: 8633392
[TBL] [Abstract][Full Text] [Related]
22. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
[TBL] [Abstract][Full Text] [Related]
23. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
Yavuz AA; Yavuz MN; Ozgur GK; Colak F; Ozyavuz R; Cimsitoglu E; Ilis E
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):734-45. PubMed ID: 12788179
[TBL] [Abstract][Full Text] [Related]
24. Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution.
Tonoli S; Bertoni F; De Stefani A; Vitali E; De Tomasi D; Caraffini B; Scheda A; Bertocchi M; Somensari A; Buglione M; Magrini SM
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):52-9. PubMed ID: 16477920
[TBL] [Abstract][Full Text] [Related]
25. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB
J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
[TBL] [Abstract][Full Text] [Related]
26. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
27. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ
Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy for stage T3b transitional cell carcinoma of the bladder.
Pollack A; Zagars GZ
Semin Urol Oncol; 1996 May; 14(2):86-95. PubMed ID: 8734736
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
[TBL] [Abstract][Full Text] [Related]
31. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
[TBL] [Abstract][Full Text] [Related]
32. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
[TBL] [Abstract][Full Text] [Related]
33. Predicting the outcome of radical radiotherapy for invasive bladder cancer.
Vale JA; A'Hern RP; Liu K; Hendry WF; Whitfield HN; Plowman PN; Sowter C; Slavin G
Eur Urol; 1993; 24(1):48-51. PubMed ID: 8365439
[TBL] [Abstract][Full Text] [Related]
34. Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.
Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
Cancer; 1994 Nov; 74(10):2819-27. PubMed ID: 7954243
[TBL] [Abstract][Full Text] [Related]
35. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder.
Mameghan H; Fisher R; Mameghan J; Brook S
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):247-54. PubMed ID: 7836076
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
37. Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary?
Tokgoz H; Turkolmez K; Resorlu B; Kose K; Tulunay O; Beduk Y
Int Braz J Urol; 2007; 33(6):777-83; discussion 783-4. PubMed ID: 18199345
[TBL] [Abstract][Full Text] [Related]
38. Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.
Matsumoto H; Matsuyama H; Fukunaga K; Yoshihiro S; Wada T; Naito K
Br J Cancer; 2004 Sep; 91(6):1025-31. PubMed ID: 15292937
[TBL] [Abstract][Full Text] [Related]
39. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.
Gospodarowicz MK; Hawkins NV; Rawlings GA; Connolly JG; Jewett MA; Thomas GM; Herman JG; Garrett PG; Chua T; Duncan W
J Urol; 1989 Dec; 142(6):1448-53; discussion 1453-4. PubMed ID: 2585617
[TBL] [Abstract][Full Text] [Related]
40. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
Coppin CM; Gospodarowicz MK; James K; Tannock IF; Zee B; Carson J; Pater J; Sullivan LD
J Clin Oncol; 1996 Nov; 14(11):2901-7. PubMed ID: 8918486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
